KalVista Pharmaceuticals, Inc.·4

May 27, 4:18 PM ET

Treanor Patrick 4

4 · KalVista Pharmaceuticals, Inc. · Filed May 27, 2022

Insider Transaction Report

Form 4
Period: 2022-05-26
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-26+17,00017,000 total
    Exercise: $8.60Exp: 2032-05-25Common Stock (17,000 underlying)
Footnotes (1)
  • [F1]The option vests over a 36 month period: 1/36th on June 26, 2022, after which 1/36th of the total shares vest monthly, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION